Silver carboxylate-TiO2/polydimethyl siloxane is a safe and effective antimicrobial with significant wound care potential
AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and...
Saved in:
| Published in | OTA international : the open access journal of orthopaedic trauma Vol. 7; no. 2S; p. e299 |
|---|---|
| Main Authors | , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Maryland, MD
Wolters Kluwer
01.03.2024
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2574-2167 2574-2167 |
| DOI | 10.1097/OI9.0000000000000299 |
Cover
| Abstract | AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.Methods:Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.Results:The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.Discussion/Clinical Relevance:Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment. |
|---|---|
| AbstractList | AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.Methods:Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.Results:The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.Discussion/Clinical Relevance:Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment. Introduction:. With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts. Methods:. Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose–response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests. Results:. The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations. Discussion/Clinical Relevance:. Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment. With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.IntroductionWith the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized in different forms, but its pharmacokinetics are difficult to control. This study details the antibacterial efficacy and cellular cytotoxicity of a formulation consisting of silver carboxylate (AgCar) released through a titanium dioxide/polydimethylsiloxane matrix with a predictable release profile on Pseudomonas aeruginosa, Acinetobacterium baumannii, and human-derived primary osteoblasts.Through an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.MethodsThrough an Institutional Animal Care and Use Committee and IRB-approved protocol, AgCar was applied to live Yucatan porcine skin and histologically analyzed for skin penetration. Graphite Furnace Atomic Absorption Spectroscopy (GFAAS) was used to measure elution of AgCar. Dose-response curves were generated through optical density to assess potency. Finally, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to quantify the cellular cytotoxicity of the novel formulation. The results were subject to statistical analysis using analysis of variance and post hoc Tukey tests.The silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.ResultsThe silver carboxylate coating demonstrated deep penetration into the epithelium at the level of the deep pilosebaceous glands in animal models. GFAAS testing demonstrated the extended elution profile of silver carboxylate over 96 hours, while 100% silver with no titanium dioxide-polydimethylsiloxane matrix fully eluted within 48 hours. 10x silver carboxylate demonstrated superior antimicrobial activity to antibiotics and other silver formulations and showed minimal cytotoxicity compared with other silver formulations.Current antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment.Discussion/Clinical RelevanceCurrent antimicrobial therapies in wound care and surgical antisepsis, such as chlorhexidine gluconate, have pitfalls including poor skin penetration and short duration of efficacy. The broad antimicrobial activity, extended elution, and deep skin penetration of this AgCar formulation show great promise for surgical site infection and wound care treatment. Novel technology to fight the growing threat of microbial resistance should be at the forefront of orthopaedic surgical site infection prevention and treatment. |
| ArticleNumber | e299 |
| Author | Allu, Sai Born, Christopher Stone, Benjamin Whitaker, Colin Garcia, Dioscaris R. Jouffroy, Elia Vishwanath, Neel Clippert, Drew Antoci, Valentin |
| Author_xml | – sequence: 1 givenname: Sai orcidid: 0000-0002-0288-4503 surname: Allu fullname: Allu, Sai email: sai_allu@brown.edu organization: The Diane N. Weiss Center for Orthopaedic Research, Rhode Island Hospital, Providence, RI; and – sequence: 2 givenname: Colin surname: Whitaker fullname: Whitaker, Colin email: colin_whitaker@brown.edu organization: Warren Alpert Medical School of Brown University, Providence, RI – sequence: 3 givenname: Benjamin surname: Stone fullname: Stone, Benjamin email: benjamin_stone@brown.edu organization: Warren Alpert Medical School of Brown University, Providence, RI – sequence: 4 givenname: Neel surname: Vishwanath fullname: Vishwanath, Neel email: neel_vishwanath@brown.edu organization: Warren Alpert Medical School of Brown University, Providence, RI – sequence: 5 givenname: Drew surname: Clippert fullname: Clippert, Drew email: drew_clippert@alumni.brown.edu organization: The Diane N. Weiss Center for Orthopaedic Research, Rhode Island Hospital, Providence, RI; and – sequence: 6 givenname: Elia surname: Jouffroy fullname: Jouffroy, Elia email: elia_jouffroy@alumni.brown.edu organization: The Diane N. Weiss Center for Orthopaedic Research, Rhode Island Hospital, Providence, RI; and – sequence: 7 givenname: Valentin surname: Antoci fullname: Antoci, Valentin email: valentin_antoci@brown.edu organization: Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI – sequence: 8 givenname: Christopher surname: Born fullname: Born, Christopher email: christopher_born@brown.edu organization: Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI – sequence: 9 givenname: Dioscaris R. surname: Garcia fullname: Garcia, Dioscaris R. email: dioscaris_garcia@brown.edu organization: Department of Orthopaedic Surgery, Warren Alpert Medical School of Brown University, Providence, RI |
| BookMark | eNp9kktv3CAUha0qlZqm-QddeNnNJAYbMKuqivoYKdIsmq7RNVzGpNhMwZ6J_32ZTlQlbVU2vM75OHB5XZyNYcSieEuqK1JJcb1Zy6vqaaNSvijOKRPNihIuzp6MXxWXKd1nDZFSckbOi-Wr83uMpYbYhYfFw4SrO7eh17vgF-MGnPrFl8n58AAjli6VUCawWMJoSrQW9eT2x9nkBqdj6Bz48uCmPnu2o7NO563yEOYsz2dguQsTZjH4N8VLCz7h5WN_UXz79PHu5svqdvN5ffPhdqVrzuSqloTXVae10GiAcmYqazgK0LSpW921xlhGBDM8i6iVWhArdNtxMFZW2XtRrE9cE-Be7aIbIC4qgFO_FkLcKoiT0x5VQ-uMpB2TgjYNb6CtraSSddwwyVqSWezEmscdLAfw_jeQVOpYDhWcVH-WI_ven3y7uRvQ6PwCEfyzMM93RterbdgfkTUnrMqEd4-EGH7MmCY1uKTR-1yVMCeVU7ZUCiGPF25O0lyOlCLavzLmL_OvjO3Jdgh-wpi--_mAUfUIfur_b_0JzpTHAw |
| Cites_doi | 10.1001/jama.2014.18614 10.1097/DSS.0000000000000375 10.1093/jac/dks284 10.2106/JBJS.M.01474 10.1016/j.watres.2008.12.002 10.2174/1566524019666190321113008 10.1016/j.msec.2014.12.072 10.1155/2013/674378 10.1089/sur.2017.220 10.3390/antibiotics11040486 10.1046/j.1472-765X.1997.00219.x 10.3390/molecules23071629 |
| ContentType | Journal Article |
| Copyright | Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association. Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association. 2024 |
| Copyright_xml | – notice: Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association. – notice: Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the Orthopaedic Trauma Association. 2024 |
| DBID | AAYXX CITATION 7X8 5PM ADTOC UNPAY DOA |
| DOI | 10.1097/OI9.0000000000000299 |
| DatabaseName | CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| EISSN | 2574-2167 |
| ExternalDocumentID | oai_doaj_org_article_42338c2b59724464a83f9295b6d59581 10.1097/oi9.0000000000000299 PMC10936150 10_1097_OI9_0000000000000299 OTAI-D-23-00045 |
| Genre | other |
| GroupedDBID | 0R~ AAAAV AAGIX AAHPQ AAIQE AAMOA AAQKA AASCR ABASU ABDIG ABVCZ ABZZY ACGFS ACILI ACLDA ACNWC ACXJB ACZKN ADGGA ADHPY ADPDF AFBFQ AFDTB AFUWQ AHOMT AHQNM AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BQLVK BYPQX DIWNM EBS EEVPB ERAAH FCALG GNXGY GQDEL GROUPED_DOAJ HLJTE IKREB IKYAY M~E OK1 OPUJH OVD OVDNE OVIDH OVLEI OXXIT RLZ RPM TEORI TSPGW AAYXX ACCJW ADGHP ADKSD ADSXY AHVBC CITATION 7X8 5PM ADTOC UNPAY |
| ID | FETCH-LOGICAL-c3659-391630bcc7ceda265d0fd6e7ac2438cb8ddf5175d60bc2f9c71f7c8b6adf90163 |
| IEDL.DBID | UNPAY |
| ISSN | 2574-2167 |
| IngestDate | Fri Oct 03 12:40:47 EDT 2025 Sun Oct 26 04:08:18 EDT 2025 Tue Sep 30 17:09:57 EDT 2025 Mon Sep 08 05:34:14 EDT 2025 Wed Oct 01 03:25:49 EDT 2025 Wed Apr 16 02:22:33 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2S |
| Keywords | silver carboxylate antimicrobial resistance surgical site infections cytotoxicity |
| Language | English |
| License | http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. cc-by-nc-nd |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c3659-391630bcc7ceda265d0fd6e7ac2438cb8ddf5175d60bc2f9c71f7c8b6adf90163 |
| Notes | Corresponding author. Address: Department of Orthopaedic Surgery, Rhode Island Hospital, 1 Hoppin St, Providence, RI 02903. E-mail address: dioscaris_garcia@brown.edu (D. R. Garcia).Supported by NIAIG grant R03AI159776 and by NIH/NIAID R25. This research also supported in part by the Diane C. Weiss Foundation, the Sipprelle Family Foundation, and the Foundation for Orthopaedic Trauma.We have no relevant conflicts of interest to disclose. Dr. Born is a Director and holds stock in BioIntraface and BI Medical. Dr. Garcia holds equity in BI Medical. We have no other relevant conflicts of interest to disclose. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-0288-4503 |
| OpenAccessLink | https://proxy.k.utb.cz/login?url=https://doi.org/10.1097/oi9.0000000000000299 |
| PQID | 2958297796 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_42338c2b59724464a83f9295b6d59581 unpaywall_primary_10_1097_oi9_0000000000000299 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10936150 proquest_miscellaneous_2958297796 crossref_primary_10_1097_OI9_0000000000000299 wolterskluwer_health_10_1097_OI9_0000000000000299 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 20240301 |
| PublicationDateYYYYMMDD | 2024-03-01 |
| PublicationDate_xml | – month: 03 year: 2024 text: 20240301 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Maryland, MD |
| PublicationPlace_xml | – name: Maryland, MD |
| PublicationTitle | OTA international : the open access journal of orthopaedic trauma |
| PublicationYear | 2024 |
| Publisher | Wolters Kluwer |
| Publisher_xml | – name: Wolters Kluwer |
| References | Lee, Pottinger, Butler-Wu (R6) 2014; 96 Elkhatib, Khalil, Ashour (R2) 2019; 19 Liau, Read, Pugh (R7) 1997; 25 Tran, Kelley, Tran (R9) 2015; 49 Park, Kim, Kim (R8) 2009; 43 LeVavasseur, Zeller (R10) 2022; 11 Horner, Mawer, Wilcox (R4) 2012; 67 Aldabaldetrecu, Tamayo, Alarcon (R11) 2018; 23 Merkow, Hu, Chung (R1) 2015; 313 Echols, Graves, LeBlanc (R3) 2015; 41 Nakase, Fukushima, Yukawa (R5) 2018; 19 Tran, Tran, Jarrell (R12) 2013; 2013 Elkhatib (R2-20240807) 2019; 19 Liau (R7-20240807) 1997; 25 Nakase (R5-20240807) 2018; 19 Aldabaldetrecu (R11-20240807) 2018; 23 Echols (R3-20240807) 2015; 41 Horner (R4-20240807) 2012; 67 Tran (R9-20240807) 2015; 49 Park (R8-20240807) 2009; 43 Tran (R12-20240807) 2013; 2013 LeVavasseur (R10-20240807) 2022; 11 Merkow (R1-20240807) 2015; 313 Lee (R6-20240807) 2014; 96 |
| References_xml | – volume: 313 start-page: 482 year: 2015 end-page: 495 ident: R1 article-title: Underlying reasons associated with hospital readmission following surgery in the United States publication-title: JAMA – volume: 96 start-page: 1447 year: 2014 end-page: 1450 ident: R6 article-title: Propionibacterium persists in the skin despite standard surgical preparation publication-title: J Bone Joint Surg Am – volume: 43 start-page: 1027 year: 2009 end-page: 1032 ident: R8 article-title: Silver-ion mediated reactive oxygen species generation affecting bactericidal activity publication-title: Water Res – volume: 19 start-page: 298 year: 2018 end-page: 302 ident: R5 article-title: Proprionibacterium acnes has low susceptibility to chlorhexidine gluconate publication-title: Surg Infect (Larchmt) – volume: 67 start-page: 2547 year: 2012 end-page: 2559 ident: R4 article-title: Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? publication-title: J Antimicrob Chemother – volume: 19 start-page: 286 year: 2019 end-page: 293 ident: R2 article-title: Integrons and antiseptic resistance genes mediate resistance of Acinetobacter baumannii and Pseudomonas aeruginosa isolates from intensive care unit patients with wound infections publication-title: Curr Mol Med – volume: 41 start-page: 667 year: 2015 end-page: 676 ident: R3 article-title: Role of antiseptics in the prevention of surgical site infections publication-title: Dermatol Surg – volume: 2013 start-page: 674378 year: 2013 ident: R12 article-title: In vivo caprine model for osteomyelitis and evaluation of biofilm-resistant intramedullary nails publication-title: Biomed Res Int – volume: 49 start-page: 201 year: 2015 end-page: 209 ident: R9 article-title: Silver doped titanium dioxide-PDMS hybrid coating inhibits Staphylococcus aureus and Staphylococcus epidermidis growth on PEEK publication-title: Mater Sci Eng C Mater Biol Appl – volume: 23 start-page: 1629 year: 2018 ident: R11 article-title: Stability of antibacterial silver carboxylate complexes against Staphylococcus epidermidis and their cytotoxic effects publication-title: Molecules – volume: 11 start-page: 486 year: 2022 ident: R10 article-title: Antibiotic therapy for prosthetic joint infections: an overview publication-title: Antibiot (Basel) – volume: 25 start-page: 279 year: 1997 end-page: 283 ident: R7 article-title: Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions publication-title: Lett Appl Microbiol – volume: 313 start-page: 482 year: 2015 ident: R1-20240807 article-title: Underlying reasons associated with hospital readmission following surgery in the United States publication-title: JAMA doi: 10.1001/jama.2014.18614 – volume: 41 start-page: 667 year: 2015 ident: R3-20240807 article-title: Role of antiseptics in the prevention of surgical site infections publication-title: Dermatol Surg doi: 10.1097/DSS.0000000000000375 – volume: 67 start-page: 2547 year: 2012 ident: R4-20240807 article-title: Reduced susceptibility to chlorhexidine in staphylococci: is it increasing and does it matter? publication-title: J Antimicrob Chemother doi: 10.1093/jac/dks284 – volume: 96 start-page: 1447 year: 2014 ident: R6-20240807 article-title: Propionibacterium persists in the skin despite standard surgical preparation publication-title: J Bone Joint Surg Am doi: 10.2106/JBJS.M.01474 – volume: 43 start-page: 1027 year: 2009 ident: R8-20240807 article-title: Silver-ion mediated reactive oxygen species generation affecting bactericidal activity publication-title: Water Res doi: 10.1016/j.watres.2008.12.002 – volume: 19 start-page: 286 year: 2019 ident: R2-20240807 article-title: Integrons and antiseptic resistance genes mediate resistance of Acinetobacter baumannii and Pseudomonas aeruginosa isolates from intensive care unit patients with wound infections publication-title: Curr Mol Med doi: 10.2174/1566524019666190321113008 – volume: 49 start-page: 201 year: 2015 ident: R9-20240807 article-title: Silver doped titanium dioxide-PDMS hybrid coating inhibits Staphylococcus aureus and Staphylococcus epidermidis growth on PEEK publication-title: Mater Sci Eng C Mater Biol Appl doi: 10.1016/j.msec.2014.12.072 – volume: 2013 start-page: 674378 year: 2013 ident: R12-20240807 article-title: In vivo caprine model for osteomyelitis and evaluation of biofilm-resistant intramedullary nails publication-title: Biomed Res Int doi: 10.1155/2013/674378 – volume: 19 start-page: 298 year: 2018 ident: R5-20240807 article-title: Proprionibacterium acnes has low susceptibility to chlorhexidine gluconate publication-title: Surg Infect (Larchmt) doi: 10.1089/sur.2017.220 – volume: 11 start-page: 486 year: 2022 ident: R10-20240807 article-title: Antibiotic therapy for prosthetic joint infections: an overview publication-title: Antibiot (Basel) doi: 10.3390/antibiotics11040486 – volume: 25 start-page: 279 year: 1997 ident: R7-20240807 article-title: Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions publication-title: Lett Appl Microbiol doi: 10.1046/j.1472-765X.1997.00219.x – volume: 23 start-page: 1629 year: 2018 ident: R11-20240807 article-title: Stability of antibacterial silver carboxylate complexes against Staphylococcus epidermidis and their cytotoxic effects publication-title: Molecules doi: 10.3390/molecules23071629 |
| SSID | ssj0001999651 |
| Score | 2.2511172 |
| Snippet | AbstractIntroduction:With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that... With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can be synthesized... Introduction:. With the rise in antibiotic resistance, new methodologies are needed to combat musculoskeletal infections. Silver is an antimicrobial that can... |
| SourceID | doaj unpaywall pubmedcentral proquest crossref wolterskluwer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
| StartPage | e299 |
| SubjectTerms | Best Paper, Basic Science Forum, 2022 OTA Annual Meeting Clinical/Basic Science |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Pb9MwFLbQLiAhBAJEgCEjcQ1NndixjzAxbUiwA5u0W-RfERYhqZZWXf573nOarRkILvRQtY0ly-899322v_eZkHeQw2zhlUtr6WGB4kuTGgZvkHkcTCeX-bgP-eWrOLkoPl_yy72rvpATNsoDj4ZbQLrPpWUGgC9kIlFomdeQ0rkRjisei65ZJtXeYiruriCO58upVk6Vi7NTNWoVTi8W5V5vc1GU7J_hzLssyfubdqWHrW7g88Nth6fZ_Y9IZt9LScePyaMdlqQfxjE8Ifd8-5QM3wKSnanVV6a7HhrAkul5OGOLVdcMLuCN0UND-9B017r1NPRU017XnurW0ZHdAX-A8G0dfoao0gRd4G4tRaoHEovgEd3ibUzYh6erbo2MI908IxfHn86PTtLd_QqpzQVXKdbc5pmxtrTeaSa4y2onfKktK8DmRjpXc4AXTkAjVitbLuvSSiO0qwFGiPw5OWi71r8glFluwOKGc6dgxea0zLiR2itd1AAQZELSydLVapTRqKbjb_BMddczCfmI7rhpiyLY8QcIjWoXGtW_QiMhbydnVjBp8CQEDNtt-goaYUlxqURC5MzLsx7nT9rwPcpvowAXyugn5P1NQPw2qC78aVDLWdRUY6nrXw3x8n8Y4hV5wACLjdS51-RgfbXxh4Cl1uZNnDa_AB9OGRE priority: 102 providerName: Directory of Open Access Journals |
| Title | Silver carboxylate-TiO2/polydimethyl siloxane is a safe and effective antimicrobial with significant wound care potential |
| URI | https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&DO=10.1097/OI9.0000000000000299 https://www.proquest.com/docview/2958297796 https://pubmed.ncbi.nlm.nih.gov/PMC10936150 https://doi.org/10.1097/oi9.0000000000000299 https://doaj.org/article/42338c2b59724464a83f9295b6d59581 |
| UnpaywallVersion | publishedVersion |
| Volume | 7 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2574-2167 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001999651 issn: 2574-2167 databaseCode: DOA dateStart: 20190101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2574-2167 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001999651 issn: 2574-2167 databaseCode: M~E dateStart: 20180101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 2574-2167 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0001999651 issn: 2574-2167 databaseCode: RPM dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1ba9swFD506cMGYxe2MW9r0WCPc5rY1u2xHS3doO1gDXRPRjdTU88OtUOa_voe2XGZswtbHkIcyxxLOpI-Sd_5BPABxzCTOGnDTDicoDiuQx3hF448FpuTnbh2HfLklB3Pki8X9GILPvaxMIP9e8n3qlx2EoP9B7vPB7DNKCLvEWzPTr_uf_fnx1GehNGU8T467g-PDkafVqR_gCw3eZEPF-VcrZaqwN-Pl5Xfv66vWvr6T4PQ0VM46V-_455cjReNHpvbDWXHf83fM3iyRqNkv3Of57Dlyhew-pZ7ujQx6lqjnQLRaHien0V786pY2dyfOb0qSJ0X1Y0qHclrokitMkdUaUnHD8EuFK-a_Efe6jyhCb_eSzxZxFOT8BZZ-vOcvA1H5lXjOUuqeAmzo8PzT8fh-oSG0MRYBaGP2o0n2hhunFURo3aSWea4MlESC6OFtRlFgGIZJooyafg040ZopmyGQITFr2BUVqV7DSQyVOPcS1NqJc75rBITqoVyUiUZQgwRQNjXXDrvhDjSfgP97LNMNwsxgANfvfdpvYx2-weWfrpulSliSXzNSOOsCmEOS5SIM8SLVDNLJRXTAN73zpFis_N7KViw1aJOMZEPSuaSBSAGXjOwOLxT5petgLeX8PJC_AGM7x3sl0yhZ_wmU9OBF6ZdsOxfC-LN_xp5C48iRG4d0e4djJrrhdtB5NXo3XbFYnfd7O4AVZYlpg |
| linkProvider | Unpaywall |
| linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1bi9QwFD6ssw8K4gUV640IPtrZmbRJk8dVXFZhdwV3YH0quWLZ2g7bDuP46z1pp4sdL2gfSi8pp0lOmi_Nd74AvMI-zKRO2tgLhwMUl-lYU9xhz2OxOdmZ6_5Dnpzy40X64YJd7MHrIRZmNH8vs4O6kL3E4LDh5_MG7HOGyHsC-4vTj4efw_pxLEtjOufZEB33h0dHvU8n0j9Clru8yJuraqk2a1Xi8e11Heavm8uOvv5TJ3R0F06G1--5J5fTVaun5vuOsuO_5u8e3NmiUXLYu8992HPVA9h8KgJdmhh1pdFOiWg0Pi_O6MGyLje2CGtOb0rSFGX9TVWOFA1RpFHeEVVZ0vND8BOKZ23xteh0ntBE-N9LAlkkUJPwFlmH9ZyCDUeWdRs4S6p8CIujd-dvj-PtCg2xSbAK4hC1m8y0MZlxVlHO7Mxb7jJlaJoIo4W1niFAsRwTUS9NNveZEZor6xGI8OQRTKq6co-BUMM0jr00Y1bimM8qMWNaKCdV6hFiiAjioebyZS_EkQ8T6GfvZb5biBG8CdV7nTbIaHcXsPTzbavMEUvia1KNoyqEOTxVIvGIF5nmlkkm5hG8HJwjx2YX5lKwYOtVk2OiEJScSR6BGHnNyOL4TlV86QS8g4RXEOKPYHrtYL9kCj3jN5maj7ww74Nl_1oQT_7XyFO4RRG59US7ZzBpr1buOSKvVr_YNrgfeW4ksQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Silver+carboxylate-TiO2%2Fpolydimethyl+siloxane+is+a+safe+and+effective+antimicrobial+with+significant+wound+care+potential&rft.jtitle=OTA+international+%3A+the+open+access+journal+of+orthopaedic+trauma&rft.au=Allu%2C+Sai&rft.au=Whitaker%2C+Colin&rft.au=Stone%2C+Benjamin&rft.au=Vishwanath%2C+Neel&rft.date=2024-03-01&rft.issn=2574-2167&rft.eissn=2574-2167&rft.volume=7&rft.issue=2S&rft_id=info:doi/10.1097%2FOI9.0000000000000299&rft.externalDBID=n%2Fa&rft.externalDocID=10_1097_OI9_0000000000000299 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2574-2167&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2574-2167&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2574-2167&client=summon |